$255M Cypress Bioscience Merger for Client Ramius

Firm News

Bloomberg reported Olshan’s client Ramius and Royalty Pharma merger agreement to acquire Cypress Bioscience, Inc., in a transaction valued at $255 million. Many national media outlets, including The Wall Street Journal, Reuters and Forbes have reported the story.

Steve Wolosky and Andrew M. Freedman represented Ramius.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.